No on Prop. 14; no need to replicate California's disappointing stem cell experiment
By Editorial Board,
San Francisco Chronicle
| 09. 24. 2020
Like MySpace, the Martha Stewart prosecution and American democratic norms, spending gobs of state money on stem cell research might sound like an artifact of the Aughts. And yet 16 years after voters agreed to borrow $3 billion to explore a promising new area of medical research, stem cells are back on the California ballot.
The state’s voters passed Proposition 71, which created the California Institute for Regenerative Medicine, in a fit of hope that stem cells could treat an array of diseases and injuries. President George W. Bush’s order limiting federally funded embryonic stem cell research on religious grounds added urgency and politics to the cause. Celebrities such as Michael J. Fox and Christopher Reeve urged Californians to step into the breach for them and countless others with incurable, often heart-rending conditions.
Now the Oakland-based agency’s backers want voters to approve an additional $5.5 billion under Proposition 14 to sustain not just a limitless possibility but also the more mundane and complex reality of the institute’s experience. Especially in a field as nascent as stem cells, science is slow,... see more
Related Articles
As the November 3 election approaches, Californians are focusing on the ballot propositions. The money spent on them this year is not only record-breaking, it’s almost unbelievable: more than $700 million so far, for and against a dozen measures.
In that context, spending by the campaign for Proposition 14, to fund the California Institute for Regenerative Medicine again, seems almost modest. As of October 17, according to the informative Ballotpedia page, proponents have raised over $16 million (including...
By Usha Lee McFarling, STAT | 10.26.2020
LOS ANGELES — This Election Day, California voters are being asked to replenish funding for the state’s ambitious stem cell research program, with a well-financed campaign that’s making heady promises about curing diabetes, paralysis, cancer, and Parkinson’s and Alzheimer’s diseases....
By Ron Leuty, San Francisco Business Times | 10.09.2020
It would dedicate $1.5 billion of its total to research and therapy for Alzheimer’s Disease, Parkinson’s Disease, stroke, epilepsy and other brain and central nervous system conditions.
By Katarina Zimmer, The Scientist | 10.24.2020
Over the course of its 16-year existence, the California Institute for Regenerative Medicine in Oakland has helped transform its state into an innovation hub of stem cell science. But CIRM announced last year that its first $3 billion of funding...
